John E. Davis
Net Worth

Last updated:

What is John E. Davis net worth?

The estimated net worth of Mr. John E. Davis is at least $5,974,990 as of 29 Nov 2021. He owns shares worth $1,296,282 as insider, has earned $751,198 from insider trading and has received compensation worth at least $3,927,510 in Artivion, Inc..

What is the salary of John E. Davis?

Mr. John E. Davis salary is $436,390 per year as Senior Vice President of Global Sales & Marketing in Artivion, Inc..

How old is John E. Davis?

Mr. John E. Davis is 60 years old, born in 1965.

What stocks does John E. Davis currently own?

As insider, Mr. John E. Davis owns shares in one company:

Company Title Shares Price per share Total value
Artivion, Inc. (CRY) Senior Vice President of Global Sales & Marketing 72,499 $17.88 $1,296,282

What does Artivion, Inc. do?

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

John E. Davis insider trading

Artivion, Inc.

Mr. John E. Davis has made 9 insider trades between 2016-2021, according to the Form 4 filled with the SEC. Most recently he purchased 600 units of CRY stock worth $10,398 on 29 Nov 2021.

The largest trade he's ever made was exercising 12,739 units of CRY stock on 25 May 2021. As of 29 Nov 2021 he still owns at least 72,499 units of CRY stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 600 $17.33 $10,398
Option
Stock Options (Right To buy) 5,402 $26.24 $141,748
Sale
Common Stock 12,739 $28.53 $363,456
Option
Common Stock 5,402 $26.24 $141,748
Purchase
Common Stock 10,000 N/A N/A
Option
ESPP 922 $16.3 $15,024
Option
Common Stock 922 $16.3 $15,024
Option
ESPP 880 $24.12 $21,228
Option
Common Stock 880 $24.12 $21,228
Option
Common Stock 3,333 $9.64 $32,130
Option
Stock Options (Right to Buy) 3,333 $9.64 $32,130
Sale
Common Stock 3,333 $9.64 $32,130
Option
Common Stock 3,391 $16.3 $55,273
Sale
Common Stock 3,391 $16.3 $55,273
Option
Stock Option (Right to Buy) 3,391 $16.3 $55,273
Option
Common Stock 3,391 $30 $101,730
Option
Stock Option (Right to Buy) 3,391 $30 $101,730
Sale
Common Stock 3,391 $30 $101,730
Option
ESPP 1,308 $16.24 $21,235
Option
Common Stock 4,372 $10.24 $44,769
Option
Stock Option (Right to Buy) 4,372 $10.24 $44,769
Option
Stock Options (Right to Buy) 4,373 $10.24 $44,780
Option
Common Stock 4,373 $10.24 $44,780
Sale
Common Stock 4,373 $10.24 $44,780
Sale
Common Stock 4,373 $10.24 $44,780
Option
Common Stock 4,373 $10.24 $44,780
Sale
Common Stock 4,373 $10.24 $44,780
Option
Stock Option (Right to Buy) 4,373 $10.24 $44,780
Option
Common Stock 4,373 $10.24 $44,780
Option
Common Stock 3,334 $9.64 $32,140
Sale
Common Stock 3,334 $9.64 $32,140
Option
Stock Option (Right to Buy) 3,334 $9.64 $32,140
Sale
Common Stock 3,333 $9.64 $32,130
Option
Stock Option (Right to Buy) 3,333 $9.64 $32,130
Option
Common Stock 3,333 $9.64 $32,130
Option
Common Stock 1,308 $16.24 $21,235
Option
Common Stock 1,305 $16.28 $21,243
Option
Stock Option (Right to Buy) 1,305 $16.28 $21,243
Option
Common Stock 2,000 $10.2 $20,400
Option
Stock Option (Right to Buy) 2,000 $10.2 $20,400

Artivion key executives

Artivion, Inc. executives and other stock owners filed with the SEC:

  • Mr. David Ashley Lee CPA, CPA (60) Executive Vice President, Chief Operating Officer & Chief Financial Officer
  • Mr. James Patrick Mackin (58) Chairman, Pres & Chief Executive Officer
  • Mr. John E. Davis (60) Senior Vice President of Global Sales & Marketing
  • Ms. Jean F. Holloway Esq. (68) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.